AEVI-002 - Sanofi, Aevi Genomic, Kyowa Hakko Kirin
AEVI-002: Initial data from P1 trial (NCT03169894) for crohn's disease in H2 2019 (Aevi Genomic Medicine) - Aug 27, 2019 - Corporate Presentation 
P1 data
https://aevigenomicmedicine.gcs-web.com/static-files/d8bade33-f328-4ad1-8b94-40d7cb78e2ed
 
Aug 27, 2019
 
 
918fc78e-09dd-4ea9-aeb7-0ef6c43b397c.jpg